RESI JPM San Francisco Featured Investors*

We expect 500+ early-stage life science investors to participate in RESI

*December 5th, 2022

Irene Blat

Sr. Dir. Search & Evaluation, Oncology, Servier

Kim Johnavon

Investment Analyst, Trutino Biosciences

Desai Dipty

Co-Chair, TiE Global Health

Shaan Gandhi

Principal of Northpond Ventures

Armin Rump

Manager of Global Business Development of Otsuka Pharmaceutical

Vlad Cernoutan

Investment Associate of LongeVC

Artemy Shumskiy

Investment Professional of LongeVC

Pengpeng Li

Associate of Lilly Asia Ventures

Brooke VanSant

Associate of Moneta Ventures

Mike Partsch

Chief Venture Officer of WARF

Brad Niles

LP of Moneta Ventures

Yasunori Murase

Senior Manager of Maruho Co., Ltd.

Klevin Lo

Associate of Milky Way Investments

Naoki Nozawa

Senior Manager of Maruho Co., Ltd.

Brent Ahrens

General Partner of Canaan Partners

Orrin Ailloni-Charas

Managing Partner of Cura Capital

Peter Alff

Senior Venture Partner of Orange Grove Bio

Marc Appel

CEO of Orange Grove Bio

Nuno Arantes-Oliveira

Partners of Clinical Research Ventures

Mel Barsky

Director of Business Development of Centre for Aging + Brain Health Innovation

Tom Beauvironnet

Investment Manager of Karista

Caleb Bell

Venture Partner of Corundum Systems Biology

Amine Benmoussa

Founding Partner of Apogee Ventures

Reetika Bhardwaj

Associate of ARCH Venture Partners

Rowan Cade

Program Manager, BARDA Ventures of Division of Research Innovation and Ventures (DRIVe)

Tsuyoshi (Josh) Chiwata

Director, US Business Development and Venture Management of Santen

Lauren Cohen

Investor of FemHealth Ventures

Juan Cueva

Director, Early Innovation Partnering of Johnson & Johnson Innovation

Ruchi Dana

Board Member of Dana Group

Anne DeGheest

Founder and Managing Director of HealthTech Capital

Phillip DiGiacomo

Vice President of Qiming Venture Partners

Steven Du

Partner of BAC Investments

Karl-Rudolf Erlemann

Owner & President of KreaMedica

Bettina Ernst

Director of BERNINA BioInvest

Xi Fang

Managing Partner of Button Capital

Nina Feng

Principal of VIVO Capital

Ye Fu

Principal of Plaisance Capital Management

Ryo Fujinami

Partner of Shinsei Capital Partners

Veronica Gabriele

Associate of Munich Re Ventures

Allison Gaw

Principal of Amplitude Ventures

Gary Gershony

Partner of BayMed Venture Partners

Oren Gez

Founder of Eight Bridges

Lana Ghanem

Managing Director of Hikma Ventures

Tom Gibbs

Director of Debiopharm Innovation Fund

David Gordon

Head of Investments of Longliv Ventures

Lu Han

Partner of Lumira Ventures

Michael Hansen

Innovation Scouting Director – North America of Eppendorf

Kenji Harada

Director & Chief Venture Capitalist of Medical Incubator Japan (MIJ)

Tadayoshi Hirata

Senior Investment Manager of Astellas Venture Management (AVM)

Brenda Hogan

Chief Investment Officer of Ontario Capital Growth Corporation (OCGC)

Maddi Holman

Associate of Touchdown Ventures Inc

Dave Hood

West Coast Outreach of Medical Technology Enterprise Consortium (MTEC)

Yen-Chen Huang

Vice President of Diamond Biofund

Mingqian Huang

Biotech Investment Analyst of Lifespan Investments

Masa Ishii

Managing Director of AZCA, Inc

Adam Jackson

Partner of Robert Bosch Venture Capital

IC Jan

Taiwan Global Angels (TGA)

Radomir Julina

Managing General Partner of Pharma Capital Partners

Yuki Kamiya

Portfolio Strategy Manager of EA Pharma Co., Ltd.

Julie Kim

Investment Analyst of FemHealth Ventures

John Kim

Principal of Aphelion Capital, LLC

Satoshi Konagai

Senior Investment Manager of Astellas Venture Management (AVM)

David Kratochvil

Managing Partner of Vista Capital Advisors

Stan Kugell

Partners of Clinical Research Ventures

Hajime Kusano

Manager, Open Innovation Department of Asahi Kasei Pharma Corporation

Patricia LaPlante

Director, Project Management of AmorChem Venture Capital Group

Jeni Lee

Partner of Pivotal bioVenture Partners

Taja Lester

Managing Partner of Health Equity Capital

Kevin Lin

BD Director of Transcenta Holding

Neil Littman

General Partner of Bioverge

Allan Liu

Director of TF Capital

Weihan Liu

Analyst of ARCH Venture Partners

Wendy Liu

Senior Associate of Plaisance Capital Management

Tim Luker

Senior Director, Emerging Technology & Innovation, Corporate Business Development of Eli Lilly and Company

Stefan Luzi

Partner of Gilde Healthcare Partners

Alexandra MacLean

EIR of Fortress Biotech

Tristan Maguet

Associate of Gilde Healthcare Partners

Bill Mantzoutsos

Angel Investor

James Mayer

Senior Manager, Investment & Venture Services of Centre for Aging + Brain Health Innovation (CABHI)

William McNamee

Director of Tarnagulla Ventures

Natalie McNamee

Director of Tarnagulla Ventures

Andrew Meadow

General Partner of Health Innovation Capital

Tamir Meiri

Senior Manager, Venture Investments of Johnson & Johnson Innovation

Neil Meyer

General Partner of BayMed Venture Partners

Kiyoshi Miyake

Senior Expert, Technology Scouting and Collaboration Technology Innovation Global, Office of CTO Olympus Corporation of Olympus Corporation

Sergio Montero

Scouting Manager of Start-Up Chile

Ivan Morace

Senior Investment Analyst of MediVentures

Richard Mulry

President & CEO of Northwell Ventures

Peter Neubeck

Partner, Head of Germany of Kurma Partners

Yoichi Omae

Business Development Director of Asahi Intecc USA Inc

Raj Pallapothu

Managing Director of Bio 9 Ventures

Milind Parate

Vice President, Corporate Development of Northwell Ventures

Luca Parolari

Senior Associate of Data Collective (DCVC)

John Pennett

Angel Investor of Mid Atlantic Bio Angels

Vik Pham

Director of Business Development of KreaMedica

David Prim

Senior Associate of Broadview Ventures

Richard Proscia

Senior Associate of Providence Ventures

Gayathri Radhakrishnan

Senior Director Venture Capital – AI Fund of Micron Ventures

Varun Ramdevan

Digital Innovation Lead of Johnson & Johnson Innovation

Rachel Rea

Director of Business Development and Licensing of Medtronic

Faye Sahai

Managing Director of Telosity Ventures

Diana Saraceni

Founder, Managing Director of Panakes Partners

Eric Schaefer

Senior Director of March of Dimes

Mary Schaheen

President of Prevail Partners

Sara Secall

Investment Director of Inveready Asset Management

Michael Shulman

Managing Director, Clinical Science & Development Strategy of Pharma Capital Partners

Shifali Singh

Associate of Aphelion Capital, LLC

Yaniv Sneor

Founding Member of Mid Atlantic Bio Angels

Catello Somma

Senior Associate of TVM Capital Life Science

Jill Sorensen

Chief Operating Officer of Medical Technology Enterprise Consortium (MTEC)

Adarsh Sowcar

External Ventures Manager of NOVA

Carl Stiewe

Managing Partner of Caelus Capital

Chelsea Sumner

NALA Healthcare AI Startups Lead of NVIDIA Corporation

George Syrmalis

CEO of Bioscience Equity Partners

Riswanto Tan

Sr. Manager, Global Business Development of Bukwang Pharmaceutical Co., Ltd.

Edwidge Thomas

VP of Clinical Solutions of Northwell Ventures

Kristin Thompson

VP, Chief Business Officer of eureKARE

Lauren Tyra

Chief Scientific Officer of Green Park & Golf Ventures

Nico Vandervelpen

Managing Partner of Bioqube Ventures

Ana-Maria Visoiu-Knapp

Managing Director of Golden Seeds

Mark Vreeke

Co-Founder of Chemical Angel Network

Kui Wang

Senior Associate of Quan Capital

Travis Whitfill

Partner of Bios Partners

Tim Xiao

Principal of Delos Capital

Lei Xu

Managing Partner, Capital Markets of Bioscience Equity Partners

Renee Yao

Global Healthcare AI Startups Business Development Lead of NVIDIA Corporation

Mark Yde

Investor of Integrated Investment Partners

Cookie Yu

Investment Director of Samsung Ventures

Jaromir Zahradka

Managing Partner of i&i Bio

David Zarling

Investor of Family Office Based in California

Cindy Zhang

Business Development Director of IHM-GBA

Cheryl Zimberlin

Investment Director of M Ventures

Akhil Akula

Vice President of New Rhein Healthcare

Amit Garg

Managing Partner of Tau Ventures

Bruce Cohen

Venture Partner of Xeraya Capital

Carey Ng

Managing Director of Mesa Verde Venture Partners

Eran Steinberg

Investor at Imaging Arts

Harneet Bath

Vice President of VEP Healthcare

Jill Goldstein

Associate of Vida Ventures

Joe Gatto

Managing Director of Seedfolio

Josephine Brysting

Venture Fellow of Health Innovation Capital

Judy Lee

General Manager of Onelin Capital

Junjun Qian

Investment Analyst of Onelin Capital

Kenny Tran

Business Development Manager of Asahi Intecc USA Inc

Lana Caron

Innovation Lead of Philips Ventures

Niels Emmerich

Vice President, Global Head Search and Evaluation of AbbVie

Nima Ronaghi

Associate of Breakout Ventures

Norm Gitis

Founder, Managing Partner of Lymo Ventures

Ravi Mistry

Individual Angel

Santosh Vetticaden

Member of NuFund Venture Group (Formerly Tech Coast Angels San Diego)

Tad Weems

Managing Director of Agilent Technologies

Walter Moos

Managing Director of Pandect Bioventures

Yoke Sin

Managing Partner of iGlobe Partners

Register RESI JPM San Francisco to Meet More Early Stage Life Science Investors

Join the RESI Investor Program

In order to best serve the investor community, as well as their strategic partners and portfolios, RESI is offering a new selection of services designed to enhance the conference experience and increase value to our investor community. The program will provide additional visibility to investors and their portfolios to help them source assets and make connections effectively at RESI events. The program also provides opportunities for involvement that tailors the event to specific objectives.

RESI’s Conference Model, Resources & Community

Attend a Digital or Hybrid RESI
Source elite assets through the partnering platform
Increase visibility to the early-stage investment ecosystem
Be featured in the Next Phase Newsletter (50K weekly readership)

Source, vet, and develop key relationships with your target audience:

Elevate firm brand to the early-stage investment community
Feature your portfolio companies to strategic partners
Get to know fundraising entrepreneurs whose technology and stage of development are a fit for your investment theme.

Access post-event attendee list, including: